Australia vs Canada: Number of isolates tested for ceftriaxone
Australia
7,222
in 2020
Canada
3,130
in 2020
Australia rank
1st
Canada rank
3rd
Number of isolates tested for ceftriaxone over time
- Australia
- Canada
How they compare
Australia currently reports 7,222 against 3,130 in Canada, a difference of 4,092.
That makes Australia's figure about 2.3 times Canada's.
Across all 11 years both countries report, Australia has been ahead every year.
Australia ranks 1st and Canada ranks 3rd of 52 countries.
Australia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Australia | Canada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,157 | 3,106 | 51 | Australia |
| 2010s | 5,607 | 3,383 | 2,224 | Australia |
| 2020s | 7,222 | 3,130 | 4,092 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Australia or Canada?
- Australia, at 7,222 against 3,130 in Canada as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Australia and Canada?
- 4,092, with Australia ahead.
- How many years of comparable data are there for Australia and Canada?
- 11 years are reported by both, from 2009 to 2020.
- How do Australia and Canada rank globally for number of isolates tested for ceftriaxone?
- Australia ranks 1st and Canada ranks 3rd of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.